Financhill
Sell
46

SWTX Quote, Financials, Valuation and Earnings

Last price:
$49.86
Seasonality move :
-8.46%
Day range:
$48.94 - $51.51
52-week range:
$28.21 - $62.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
19.79x
P/B ratio:
7.97x
Volume:
1.7M
Avg. volume:
3.2M
1-year change:
3.35%
Market cap:
$3.8B
Revenue:
$191.6M
EPS (TTM):
-$3.48

Earnings Data

Next earnings date for SWTX
May 02
2025
Most recent earnings per share
-$1.04
Missed by $0.33
(Feb 20/2025)
Consensus Estimate
-$0.71
(Feb 20/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

SWTX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
05/02/2025 Q1 $66.9M -- -- -$0.74 --
02/20/2025 Q4 $60.5M $61.5M -$1.04 -$0.71 -$0.33
11/12/2024 Q3 $55.1M $49.3M -$0.72 -$0.76 $0.04
08/07/2024 Q2 $34.6M $59.7M -$0.54 -$1.07 $0.53
05/02/2024 Q1 $13.1M $21M -$1.18 -$1.06 -$0.12
02/27/2024 Q4 $903.3K $5.4M -$1.45 -$1.10 -$0.35
11/02/2023 Q3 -- -- -$1.27 -$1.22 -$0.05
08/02/2023 Q2 -- -- -$1.25 -$1.08 -$0.17
05/03/2023 Q1 -- -- -$1.18 -$1.10 -$0.08
02/28/2023 Q4 -- -- -$1.17 -$1.01 -$0.16
11/03/2022 Q3 -- -- -$1.37 -$1.05 -$0.32
08/04/2022 Q2 -- -- -$1.41 -$1.15 -$0.26
05/05/2022 Q1 -- -- -$1.26 -$1.02 -$0.24
02/24/2022 Q4 -- -- -$1.16 -$0.73 -$0.43
11/04/2021 Q3 -- -- -$0.84 -$0.67 -$0.17
08/04/2021 Q2 -- -- -$0.97 -$0.69 -$0.29
05/06/2021 Q1 -- -- -$0.62 -$0.44 -$0.18
02/25/2021 Q4 -- -- $0.30 $0.08 $0.22
11/12/2020 Q3 -- -- -$0.51 -$0.43 -$0.08
08/12/2020 Q2 -- -- -$0.47 -$0.35 -$0.12
05/12/2020 Q1 -- -- -$0.37 -$0.35 -$0.02
03/12/2020 Q4 -- -- -$0.38 -$0.32 -$0.06
11/12/2019 Q3 -- -- -$1.77 -$0.41 -$1.36

SpringWorks Therapeutics Earnings Questions

  • How Much did SpringWorks Therapeutics Generate in Revenue Last Quarter?

    SpringWorks Therapeutics reported $61.5M worth of top line sales in its most recent quarter.

  • Did SpringWorks Therapeutics Beat Earnings Last Quarter?

    SpringWorks Therapeutics announced earnings per share of -$1.04 which represents a miss of analyst forecast a -$0.71 per share.

  • Is SpringWorks Therapeutics Profitable?

    SpringWorks Therapeutics reported $56M that represents $0.75 per share over the last quarter.

  • What is the Analyst Consensus for SpringWorks Therapeutics EPS Next Year?

    SpringWorks Therapeutics's earnings are forecast to decrease from -$3.48 per share to -$3.16 per share next year representing a decrease of -32.97%.

  • When is SpringWorks Therapeutics's Earnings Date?

    SpringWorks Therapeutics's next earnings date is May 2, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

2 Dividend Stocks to Buy in a Recession
2 Dividend Stocks to Buy in a Recession

While many economists and investors initially expected 2025 to be…

Is Ford Stock Undervalued Amid the EV Transition?
Is Ford Stock Undervalued Amid the EV Transition?

There is a lot going on in the electric vehicle…

Is Goldman Sachs Stock a Buy Sell or Hold?
Is Goldman Sachs Stock a Buy Sell or Hold?

When the Federal Reserve started hiking rates in 2022, banks’…

Stock Ideas

Buy
52
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
56
Is NVDA Stock a Buy?

Market Cap: $3T
P/E Ratio: 41x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Alerts

Sell
49
SMTC alert for Mar 17

Semtech [SMTC] is down 0.49% over the past day.

Buy
62
PLPC alert for Mar 17

Preformed Line Products [PLPC] is up 3.8% over the past day.

Sell
50
NUTX alert for Mar 17

Nutex Health [NUTX] is up 4.82% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock